Research
Review examines glucagon receptor contribution to weight loss
Investigators assess how the glucagon arm of triple agonism may add to energy expenditure beyond incretin effects.
Analysis
What this means
Full analysis for this development is in preparation. Published entries will set out what was reported, how it fits the existing evidence base, and what would need to change for the conclusion to shift.
Retatrutide Report does not provide dosing guidance, sourcing information or treatment recommendations. Coverage is limited to trial data, published literature and regulatory documents.
- Category
- Research
- Publication date
- 18 Aug 2026
- Source
- Peer-reviewed journal